|
|
Dr Christopher Etheridge
PhD, MRSC, MCPP, BSc (Hons) Phyto, BSc
(Hons) Chem, CChem, DoIC, ARCS Integrated Cancer Specialist |
|
Dr
Christopher Etheridge’s qualifications, experience and publications
Chris
Etheridge is a leading Integrated Cancer Specialist with
extensive experience as a practitioner, researcher and writer in the cancer
field. He is also one of Britain’s
foremost Medical Herbalists (Phytotherapists) with his own dedicated herbal
medicine practices, chrisetheridgeherbalist.co.uk or integratedherbalhealthcare.co.uk.
In the past, Dr Etheridge has worked
with Patricia Peat as Director of Research and Head Consultant for Cancer
Options, and with Dr Rosy Daniel (formerly of the Bristol Cancer Centre and now
the Penny Brohn Centre) to create an integrated workbook for recently diagnosed
cancer patients.
He is a
guest lecturer at the Centre for Nutrition Education (cnelm.co.uk), the Institute of Optimum Nutrition (ION) (ion.ac.uk), the Northern College of
Acupuncture (chinese-medicine.co.uk) and The Haven (thehaven.org.uk). Chris is a writer for the
charity Action for ME’s magazine (afme.org.uk), and scientific advisor for Advanced
Orthomolecular Research (aoreurope.co.uk) and the charities Yes to Life
(yestolife.org.uk) and Kids Integrated Cancer
Treatments (kict.info).
Chris holds a first class honours BSc and a PhD in Medicinal
Chemistry from Imperial College, London. He was a Lecturer and Research Fellow in Gene Therapy in Imperial’s
Department of Chemistry and in the Department of Biochemistry
and Molecular Genetics at St Mary’s
Hospital, where he also received further medical training, from 1995-99. His research into gene therapy
for cancer, cystic fibrosis, rheumatoid arthritis and Parkinson’s disease
produced numerous publications (listed below)
and three commercial medical patents, which resulted in a £3.5 million
investment from Mitsubishi for the construction of a new Genetic Therapies
Centre at Imperial College. Chris also co-founded a genetic therapy company,
IC-Vec, through Imperial Innovations Ltd, in order to manufacture and supply
his patented drugs for clinical use, and to carry out further gene therapy
research to develop improved treatments for cystic fibrosis and rheumatoid
arthritis. IC-Vec was subsequently purchased by the Mitsubishi Chemical
Company.
Chris believes passionately in the
medicinal use of herbs as safer, effective alternatives and adjuncts to
orthodox medicines, and he is fully committed to a holistic “whole person”
approach to treating his patients. These values led him to complete his
professional training on the four-year Herbal Medicine degree programme at the College of
Phytotherapy, East Sussex. He graduated in 2006 with a first class honours BSc
and published his National Institute of Medical Herbalists (NIMH) award-winning
dissertation on quality control in herbal medicine in the Journal of Pharmacy and Pharmaceutical
Sciences. (You can read the article here.)
Rewrite
Professional
membership
Chris Etheridge is a Member of the College of
Practitioners of Phytotherapy (MCPP).
The College of Practitioners of Phytotherapy (CPP)
is a professional membership organisation established in 1991 to
ensure the highest standards of excellence in herbal medicine
(phytotherapy). All members of the CPP must have a professional qualification
in herbal medicine and regularly participate in a professional training scheme,
Continuing Professional Development (CPD), which ensures that they are up to
date with the latest research in both medicine and herbal medicine.
For further information
on the CPP, please visit www.phytotherapists.org.
RSC
List of publications
1. “1-Benzyoxy-3-(p-tolylsulfonyl)propene as an acrolein
β-anion equivalent. Synthesis of 4-substituted
2-butenolides”,
Craig, D, Etheridge, CJ, Smith, AM TETRAHEDRON
LETTERS 1992, 33 (48),
7445-7446.
2. “1-Benzyloxy-3-(p-tolylsulfonyl)alkenes as enal β-anion
equivalents. Synthesis of 2,3-disubstituted furans”, Craig, D,
Etheridge, CJ TETRAHEDRON LETTERS 1993, 34 (46), 7487-7488.
3. “(Alkoxyallyl)sulfones as enal β-anion equivalents. Synthesis of 5-substituted
2(5H)-furanones”, Craig, D, Etheridge, CJ,
Smith, AM TETRAHEDRON 1996, 52 (48), 15267-15288.
4. “(Alkoxyallyl)sulfones as enal and enone β-anion
equivalents. Synthesis of mono-, di-
and trisubstituted furans”, Craig, D, Etheridge, CJ TETRAHEDRON
1996, 52 (48), 15289-15310.
5. “Microspheres, microcapsules and liposomes”,
Cooper, RG, Etheridge, CJ, Miller, AD, Stewart, L (Ed. Arshady_R),
John Wiley & Sons, 1997.
6. “Intrathecal administration of cationic liposome vectors for gene delivery to the
central nervous system”, McQuillin, A, Murray, K,
Stewart, L, Etheridge, CJ, Cooper, RG, Miller, AD, Gurling,
HMD AMERICAN JOURNAL OF MEDICAL GENETICS
1997, 74 (6), 600.
7. “Optimisation of liposome mediated transfection
of a neuronal cell line”, McQuillin, A, Murray,
KD, Etheridge, CJ, Stewart, L, Cooper, RG, Brett, PM, Miller, AD, Gurling, HMD NEUROREPORT
1997, 8 (6), 1481-1484.
8. “Polyamine analogues of 3 beta-[N-(N',N'-dimethylaminoethane)carbomoyl]-cholesterol (DC-Chol)
as agents for gene delivery”, Cooper, RG, Etheridge, CJ, Stewart, L,
Marshall, J, Rudginsky, S, Cheng, SH, Miller, AD, CHEMISTRY-A EUROPEAN JOURNAL 1998, 4 (1), 137-151.
9. “Endothelial cell transfection with cationic liposomes and herpes simplex thymidine
kinase mediated killing”, Fife, K, Bower, M, Cooper, RG, Stewart, L,
Etheridge, CJ, Coombes, RC, Buluwela,
L, Miller, AD, GENE THERAPY 1998, 5 (5). 614-620.
10. “Enhanced in vitro and in vivo gene delivery using cationic agent
complexed retrovirus vectors”, Themis, M, Forbes,
SJ, Chan, L, Cooper, RG, Etheridge, CJ, Miller, AD, Hodgson, HJF, Coutelle, C, GENE
THERAPY 1998, 5 (9), 1180-1186.
11. “Cationic liposome-mediated DNA transfection in organotypic explant cultures of the ventral mesencephalon”,
Murray, KD, McQuillin, A, Stewart, L, Etheridge, CJ,
Cooper, RG, Miller, AD, Gurling, HMD GENE THERAPY 1999, 6 (2), 190-197.
12. “Comparison of rosmarinic
acid content in commercial tinctures produced from fresh and dried lemon balm
(Melissa officinalis)”, Sanchez-Medina, A, Etheridge,
CJ, Hawkes, GE, Hylands, PJ,
Pendry, BA, Hughes, MJ, Corcoran, O, Journal
of PharmACY and Pharmaceutical Science 2007, 10 (4), 455-463.
13. “Natural herbal relief for menopausal symptoms”, Bailey C, Etheridge CJ, ADVANCING
NUTRITION 2012, January issue.